T07-O-03 Benign prostatic hyperplasia plus chronic prostatitis - new possibility of treatment - 27/06/08
Résumé |
Introduction |
Benign prostatic hyperplasia (BPH) is a common problem of men aged 60 years and above. Enlargement of the prostate can exert pressure on the urethra; resulting is gradual obstruction to urine flow. The expressed violation of urination often is explained also by accompanying prostatitis. So medicine treatment BPH alone is insufficiently effective.
Material and Methods |
86 patients with BPH and co-morbidity chronic prostatitis were enrolled in study. Control group (39 patients) received Tamsulosin during 3 months and doxiciclinum for 10 days. Experience group (47 patients) received also laser therapy. Efficiency was assessed using IPSS, uroflowmetry, prostate secretion analysis and bacteriological tests. The first examination was before the treatment, and the final estimation was in 3 months.
Results |
In control group symptom scores reduced by 38% and flow rates improved by 24%. In experience group improvement in symptom score and flow rates was 54% and 32% accordingly. In control group 58% patients had signs of prostate inflammation, growth of microbial flora and there were only 16% such patients in experience group. No adverse effects were marked.
Conclusions |
Simultaneous application of laser therapy, doxiciclinum and Tamsulosin in patients with co-morbidity BPH and prostatitis resulted in cumulation of antibacterial in a prostate tissue, removal of spasm, facilitation of out flow of a prostate secret and an inflammatory exudate, cupping of dysuria. All the I-PSS scores decreased significantly during the treatment.
Le texte complet de cet article est disponible en PDF.Plan
Vol 17 - N° S1
P. 101-102 - janvier-mars 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?